Coding of Ovarian Cancer Diagnosis Delayed
Free text contains extra information relating to the diagnosis of ovarian cancer, and in some cases indicates a time lag between the diagnosis and coding in the medical record, according to a study published online Feb. 23 in BMJ Open.
THURSDAY, March 10 (HealthDay News) -- Free text contains extra information relating to the diagnosis of ovarian cancer, and in some cases indicates a time lag between the diagnosis and coding in the medical record, according to a study published online Feb. 23 in BMJ Open.
A. Rosemary Tate, D.Phil., from Brighton and Sussex Medical School in the United Kingdom, and colleagues analyzed free text records from the General Practice Research Database of 344 women with a Read code indicating ovarian cancer between June 2002 and May 2008 for the date of diagnosis, and use of the word ovary. The diagnosis date recorded in the free text was compared to the date at which the diagnosis was first coded.
The investigators found that, in 22 percent of the cases, the text confirmed a diagnosis before the coded date; in 10 percent of cases, the text diagnosis was more than four weeks earlier. In 90 percent of the cases, the free text contained some information relating to the ovary but definite diagnosis of ovarian cancer was present in only 45 percent of cases. Four patients with coding for ovarian cancer did not have ovarian cancer and, in 10 percent of coded cases, the diagnosis was ambiguous or suspected.
"For diseases which rely on hospital consultants for diagnosis, free text (particularly letters) is invaluable for accurate dating of diagnosis and referrals and also for identifying misclassified cases," the authors write.
Related Content
- Society Gynecologic Oncology (SGO) - Annual Meeting on Women's Cancer
- Understanding Referral Patterns for Ovarian Cancer
- Educational Tutorial: Case Report: Ovarian Cancer
- Educational Tutorial: Carcinoma of the Vulva
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
